Senior Medical Director, Solid Tumor Oncology Strategy

BioSpace; California; On-site; USD 308,000 - 462,000; Full time

Benefits offered by this job

Job summary

Jazz Pharmaceuticals in the United States seeks a Senior Medical Director for Solid Tumor Oncology to shape medical strategy across the drug development lifecycle and lead scientific partnerships. This senior clinical leader will oversee trial design, biomarker strategies, safety governance, and regulatory interactions, ensuring patient-centric development and alignment with oncology strategy.

The role offers broad cross-functional collaboration and opportunities to influence portfolio strategy,

Qualifications

• MD or MD/PhD with board certification in Oncology required.
• 10+ years of clinical and/or pharma industry experience in oncology.
• Demonstrated leadership across global clinical development.

Responsibilities

• Provide strategic medical oversight for solid tumor programs from early development through registration and post-approval.
• Serve as medical authority for assets, ensuring safety, regulatory compliance, and scientific integrity.
• Guide trial design, endpoints, biomarkers, and translational integration.
• Oversee medical monitoring and safety governance activities.
• Collaborate with Clinical Development, Regulatory, Biostatistics, and Operations to deliver trials.
• Contribute to publication strategy and external scientific engagement.

Skills

Strategic thinking

Communication

Stakeholder management

Leadership

Ethical judgment

Education

MD or MD/PhD

Board certification in Oncology or Hematology-Oncology

Job description

Jazz Pharmaceuticals in the United States seeks a Senior Medical Director for Solid Tumor Oncology to shape medical strategy across the drug development lifecycle and lead scientific partnerships. This senior clinical leader will oversee trial design, biomarker strategies, safety governance, and regulatory interactions, ensuring patient-centric development and alignment with oncology strategy.

The role offers broad cross-functional collaboration and opportunities to influence portfolio strategy,